News - Lindis Blood Care

Lindis’ Catuvab is designed to remove tumor cells from surgical blood

Lindis’ Catuvab is designed to remove tumor cells from surgical blood

kuehnert2021-05-21T08:14:31+02:0002.04.2021|News|

Finance News Lindis’ Catuvab is designed to remove tumor cells from surgical blood Hennigsdorf, Berlin, Germany - April 2, 2021. Lindis Blood Care GmbH launched [...]

Lindis Initiates Clinical EU Certification Study REMOVE with CATUVAB®

Juergen Sonneborn2021-07-26T13:20:08+02:0018.03.2021|News|

Finance News Lindis Blood Care Initiates Multicenter Clinical EU Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood Hennigsdorf, Berlin, Germany - [...]

Financing News

aleksandar2021-03-11T14:42:57+01:0011.12.2019|News|

Finance News Over 5 million euros for Lindis Blood Care: development of a new product for the removal of tumor cells from surgical blood Hennigsdorf [...]